Georges Gemayel, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 18,787 shares at $53.71 ($1.0M) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Open-market sale of $1.0M SUPN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.71 | 10,000 | $537K | 53.6% |
| 2 | $53.00 | 8,787 | $466K | 46.4% |
| Total | $53.38 avg | 18,787 | $1.0M | 100% |
| Filing → |
| SUPN | SELL | 2024-09-17 | $557K | — | Filing → |
| MNTA | SELL | 2020-08-07 | $330K | — | Filing → |
| MNTA | SELL | 2020-07-30 | $300K | — | Filing → |